These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 10702550)
1. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis. Cabellos C; Martínez-Lacasa J; Tubau F; Fernández A; Viladrich PF; Liñares J; Gudiol F J Antimicrob Chemother; 2000 Mar; 45(3):315-20. PubMed ID: 10702550 [TBL] [Abstract][Full Text] [Related]
2. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis. Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968 [TBL] [Abstract][Full Text] [Related]
3. Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis. Cabellos C; Fernàndez A; Maiques JM; Tubau F; Ardanuy C; Viladrich PF; Liñares J; Gudiol F Antimicrob Agents Chemother; 2003 Jun; 47(6):1907-11. PubMed ID: 12760866 [TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis. Lutsar I; Ahmed A; Friedland IR; Trujillo M; Wubbel L; Olsen K; McCracken GH Antimicrob Agents Chemother; 1997 Nov; 41(11):2414-7. PubMed ID: 9371342 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916. Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Fernández Viladrich P; Gudiol F J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686 [TBL] [Abstract][Full Text] [Related]
6. Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis. Martínez-Lacasa J; Cabellos C; Martos A; Fernández A; Tubau F; Viladrich PF; Liñares J; Gudiol F J Antimicrob Chemother; 2002 Mar; 49(3):507-13. PubMed ID: 11864951 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae. Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562 [TBL] [Abstract][Full Text] [Related]
8. Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Cabellos C; Martinez-Lacasa J; Martos A; Tubau F; Fernández A; Viladrich PF; Gudiol F Antimicrob Agents Chemother; 1995 Sep; 39(9):2158-60. PubMed ID: 8540738 [TBL] [Abstract][Full Text] [Related]
9. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. Antimicrob Agents Chemother; ; . PubMed ID: 10898696 [TBL] [Abstract][Full Text] [Related]